Myelodysplastic Syndromes (MDS)

Coordinating Care for Patients With Bone Marrow Failure

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Bone Marrow Transplant
Living Well with Bone Marrow Failure
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric Bone Marrow Failure Diseases
Presenter(s)
Beena Mathew, MSN, OCN, RN

This informative 30-minute webinar provides practical recommendations for how health care providers can coordinate care for their bone marrow failure patients. Communication among members of the entire health care team managing these patients will also be discussed. This webinar…

AAMDSIF Resources for Health Professionals

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Bone Marrow Transplant
Living Well with Bone Marrow Failure
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric Bone Marrow Failure Diseases
Presenter(s)
Bhumika Patel, MD

Dr. Patel discusses how health care providers, especially those in community settings, can connect patients with aplastic anemia, MDS, or PNH with AAMDSIF patient education resources and support. View, download, or order AAMDSIF patient guides and fact sheets here: https://www…

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s)

Original Publication Date
Article Source
External Web Content

Abstract NRAS and KRAS mutations, commonly identified alongside ancestral co-mutations, are generally regarded as pathogenic in adults presenting with monocytosis and/or cytopenia(s). However, their significance in isolation is not well defined. We studied a multi-institutional…

Oral Decitabine/Cedazuridine Plus Venetoclax Yields 91% ORR in High-Risk MDS and CMML

Original Publication Date
Article Source
External Web Content

Key Takeaways The combination therapy achieved a 91% overall response rate, with 45% complete remission and 46% marrow complete remission rates. Median overall survival was 30 months, with 1- and 3-year survival rates of 68.8% and 40.7%, respectively. SHOW MORE Decitabine…

Health Equity for Non Transplant Treatment Panel Discussion

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Eileen Hu, MD, PhD
Yazan F. Madanat, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…

Health Equity for Aplastic Anemia, MDS, and AML Transplantation Panel Discussion

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Julio Alvarenga Thiebaud, MD.
Clayton Jackson, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…

ASH 2024 Research Summaries (MDS and AML)

M-D-S and A-M-L Research Summaries for Patients from ASH 2024
This publication offers summaries of selected abstracts presented at the Annual Meeting of the American Hematology Society held in December 2024. It provides new and updated information about research into the diagnosis…
Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.